Dialectical Behavior Therapy for Adults With Autism Spectrum Disorders

Not Applicable

Recruiting

• Conditions: Autism Spectrum Disorders

• Registration Number: NCT04737707
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Dialectical Behavior Therapy (DBT; Linehan, 1993) effectively diminishes emotion dysregulation and self-harm behaviors in a number of disorders. However, to our knowledge, no studies have investigated the efficacy of DBT to treat emotional dysregulation associated with self-harm and suicidal behaviors in adults with ASD without intellectual disability. This randomized controlled study trial aims to assess the efficacy of a 5-month DBT intervention in adults with ASD without intellectual disability who present with self-harm and/or suicidal behaviors.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-01-25
• Study First Submitted QC: 2021-02-01
• Study First Posted: 2021-02-04
• Study Start: 2021-04-16
• Status Verified: 2024-08
• Last Update Submitted: 2024-08-16
• Last Update Posted: 2024-08-19
• Primary Completion: 2024-09-01
• Study Completion: 2024-09-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• ≥ 18 years old
• ASD diagnosis according to the DSM-5
• IQ ≥ 70
• Suicidal ideas, suicidal attempts and/or self-harm behaviors 6 months prior to the inclusion
• Able to understand and consent to the research aims
• Membership in a health insurance fund

Exclusion Criteria

• complete hospitalization
• ongoing CBT or DBT
• past DBT
• schizophrenia disorders
• under guardianship

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Difficulties in Emotion Regulation Scale (DERS)	11 months follow-up	The minimum value of the DERS scale is 0 and the maximum is 180. The higher the scores, the more severe the deregulation.

Trial Locations

Locations (1)

Service de psychiatrie; 🇫🇷 Strasbourg, France